NetraMark Holdings Inc AINMF

Primary Symbol: C.AIAI

Healthcare Medical Devices

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.

CSE:AIAI - Post by User

NetraMark Holdings Inc > Keep your eye on Nurosene Health in 2022

<< Previous

Bullboard Posts

Next >>

Post by XeniaTechieon Dec 31, 2021 1:19pm

106 Views

Post# 34274331

Keep your eye on Nurosene Health in 2022

What’s your point of entry? Q4 was huge for Nurosene, hitting all-time highs in November with a promise of much more with mHealth opportunities tapping into the massive $300B+ market. Definitely one to keep your eye on going into 2022, this blog has solid analysis from a portfolio manager with key insights into Nurosene’s 4-pronged approach generating revenues. https://www.cantechletter.com/2021/11/keep-your-eye-on-nurosene-health-this-portfolio-manager-says/#

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions